An estimated 100 million Americans suffer from chronic pain — more than those affected by heart disease, cancer, and diabetes combined, according to The National Academies of Science, Engineering, and Medicine. How best to manage that pain in the face of a nationwide opioid crisis is the question on many practitioners’ minds.
The Connecticut Pain Consortium — a translational pain research and education collaboration between UConn Health, the UConn schools of Medicine and Nursing, and The Jackson Laboratory — aims to help answer it.
Given the broad range of research interests and funding opportunities related to pain, the founders envision that centers across the University and nearly every UConn school and college — particularly the schools of Dental Medicine and Pharmacy — will join the consortium to build mutually beneficial collaborations. Experts from Yale University and hospitals including Connecticut Children’s Medical Center will also be involved.
“There is a clear need for more basic and translational research on human pain and pain management,” says the Consortium’s director, mathematician and computational biologist Reinhard Laubenbacher, a joint faculty member at UConn Health and The Jackson Laboratory for Genomic Medicine.
“And there is a critical unmet need for education and training of providers and patients. This is a great opportunity to deploy our capabilities in pain research and addiction together with our Connecticut partners in an exciting and much-needed statewide initiative.”
The Consortium, the first of its kind in the Connecticut medical community, will establish a portal for pain-related health care data and facilitate research collaborations that leverage state and national resources. It will aim to translate that research into cutting-edge pain management solutions and raise awareness of the many facets of pain, pain management, and potential related ramifications including opioid addiction. The Consortium will contribute to a curriculum on pain research and management for health care providers.
The launch is being funded by a $55,000 planning grant from the Mayday Fund, whose mission is to support projects that close the gap between knowledge and practice in the treatment of pain, to the UConn Foundation. The Consortium has also received support from the UConn Office of the Vice President for Research, the schools of Nursing and Medicine, and the Jackson Laboratory for Genomic Medicine.
“This new consortium builds upon strengths already existing in the School of Medicine, with an existing core of faculty focused on pain research,” says Dr. Bruce T. Liang, dean of the School. “Thanks to this grant, we believe there will be numerous opportunities for advancement in the study and treatment of pain.”